Ripple Therapeutics Corporation Canada
Research
Date range: 1 March 2021 - 28 February 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Ripple Therapeutics Corporation published between 1 March 2021 - 28 February 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 1 | 0.68 |
Outputs by subject (Share)
| Subject | Count | Share |
|---|---|---|
| Chemistry | 1 | 0.68 |
| Life Sciences | 1 | 0.68 |
| Physical Sciences | 1 | 0.68 |
Share output for the past 5 years
| 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Compare Ripple Therapeutics Corporation with other institutions
Collaboration
Date range: 1 March 2021 - 28 February 2022
International vs. domestic collaboration by Share
- 60.59% Domestic
- 39.41% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Ripple Therapeutics Corporation by Share (3 total)
-
Ripple Therapeutics Corporation and McMaster University
(0.85)
-
Ripple Therapeutics Corporation and University of Toronto (U of T)
(0.72)
-
Ripple Therapeutics Corporation and Ted Rogers Centre for Heart Research
(0.69)
Top 10 international collaborators with Ripple Therapeutics Corporation by Share (2 total)
-
Ripple Therapeutics Corporation and University of Montana (UMT)
(0.74)
-
Ripple Therapeutics Corporation and Xyzagen, Inc.
(0.74)
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.